Cousins Properties vs Healthcare Realty Trust
CUZ and HR side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CUZ and HR compare
Healthcare Realty Trust is the larger company, worth 1.3 times as much as Cousins Properties ($6.5B against $4.9B).
Cousins Properties grew revenue faster over the last twelve months (8.5% versus −5.8% for Healthcare Realty Trust).
Cousins Properties keeps more of each dollar of sales as profit, with a net margin of 1.4% compared with −4.0% at Healthcare Realty Trust.
Both pay dividends: Cousins Properties yields 4.3% and Healthcare Realty Trust 3.8%.
Cousins Properties scores higher on the StockData Score (8 against 3 for Healthcare Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CUZ | HR |
|---|---|---|
| Size and price | ||
| Market cap | $4.9B | $6.5B |
| Share price | $29.64 | $19.16 |
| Change, 1 year | 13.5% | 4.4% |
| Change, 5 years | −24.3% | −41.2% |
| Beta (5Y) | 0.91 | 0.51 |
| Employees | 351 | 539 |
| StockData Score | ||
| Total score | 8 (better) | 3 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 | 1 |
| Health score | 0 | 0 |
| Dividend score | 2 (better) | 1 |
| Valuation | ||
| P/E | 329× | – |
| P/S | 4.7× (better) | 5.7× |
| P/B | 1.1× (better) | 1.6× |
| EV/EBITDA | 4.3× | – |
| Fair value | $34.35 | $16.49 |
| Margin of safety | 13.7% (better) | −16.2% |
| Growth | ||
| Revenue growth (TTM) | 8.5% (better) | −5.8% |
| Revenue growth, 5Y average | 6.1% | 18.8% (better) |
| Net income growth (TTM) | −74.2% | – |
| EPS growth (TTM) | −74.3% | – |
| EPS growth, 5Y average | −31.6% | – |
| Profitability | ||
| Gross margin | 68.4% | – |
| Operating margin | 68.3% | – |
| Net margin | 1.4% (better) | −4.0% |
| Return on equity | 0.32% (better) | −1.0% |
| Return on invested capital | 12.3% | – |
| Financial health | ||
| Interest coverage | 4.0× | – |
| Altman Z-score | 1.05 (better) | 0.93 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 4.3% (better) | 3.8% |
| Payout ratio | 1445% | – |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 1.3% (better) | −1.7% |
| Buyback yield | – | 0.05% |
| Shareholder yield | 4.3% (better) | 3.8% |
| Ownership | ||
| Held by institutions | 105% | 112% |
| Held by insiders | 1.1% | 5.0% |
| Insider net buying, 12 months | −$178K (better) | −$745K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 8.1% | 5.3% |
Go deeper
- CUZ stock overview
- CUZ income statement
- CUZ valuation and score
- HR stock overview
- HR income statement
- HR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.